The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
R
|
Rithm Capital Corp
F:14N1
|
US |
|
Saipem SpA
MIL:SPM
|
IT |
|
Norsk Hydro ASA
OSE:NHY
|
NO |
|
Kao Corp
OTC:KAOOY
|
JP |
|
W
|
Weichai Power Co Ltd
XMUN:WI4
|
CN |
|
Sika AG
OTC:SKFOF
|
CH |
|
K
|
Kingspan Group PLC
DUS:KRX
|
IE |
|
S
|
Sino Land Co Ltd
XMUN:SNO
|
HK |
|
V
|
Vericel Corp
XMUN:ATQP
|
US |
Rithm Capital Corp (14N1)’s 12-month stock price forecast through September 2027 has a consensus target of €11.71, implying 46% upside. The forecast is based on price targets from 12 Wall Street analysts.
Past growth per year Not enough data
Average annual growth cannot be calculated for these periods.
Explore analyst estimates, growth and forecast ranges.
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
According to Wall Street analysts, the average 1-year price target for
14N1 is 11.71 EUR with a low forecast of 11.15 EUR and a high forecast of 12.98 EUR.
Over the last 12 years, the compound annual growth rate for Revenue has been 25%. The projected CAGR for the next 3 years is -23%.
Over the last 12 years, the compound annual growth rate for Operating Income has been 9%. The projected CAGR for the next 2 years is 32%.
Over the last 12 years, the compound annual growth rate for Pre-Tax Income has been 10%. The projected CAGR for the next 3 years is 31%.
Over the last 12 years, the compound annual growth rate for Net Income has been 7%. The projected CAGR for the next 3 years is 38%.
AI-generated answers can contain mistakes, outdated facts, or incomplete information. Always verify important details before making decisions.
The AI Assistant is designed for research and education. It does not provide personalized investment, legal, or tax advice.
We rebuilt our DCF valuation models from the ground up and upgraded how Intrinsic Value is calculated. Alpha Spread now selects the method that best fits each company.
You can now see how the new methodology performed across thousands of stocks on our new Valuation Backtest page. We update the results at the end of every month.
By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.
By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.
Stock intrinsic value is the real worth of a company's stock, based on its financial health and performance.
Instead of looking at the stock's current market price, which can change due to people's opinions and emotions, intrinsic value helps us understand if a stock is truly a good deal or not.
By focusing on the company's actual financial strength, like its earnings and debts, we can make better decisions about which stocks to buy and when.
Read more